Who owns the MIRATI THERAPEUTICS trademark?

The MIRATI THERAPEUTICS trademark is owned by Mirati Therapeutics, Inc..

What class is the MIRATI THERAPEUTICS trademark registered in?

The MIRATI THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for MIRATI THERAPEUTICS?

The USPTO serial number for MIRATI THERAPEUTICS is 90739574.

What is the registration number for MIRATI THERAPEUTICS?

MIRATI THERAPEUTICS is registered under USPTO registration number 6713167.

Sealvo

Home Search: MIRATI THERAPEUTICSMIRATI THERAPEUTICS #90739574

Back

Updated Oct 12, 2026·24 searches this week

View on USPTO TSDR Find similar marks

MIR

USPTO Trademark Record

REGISTERED

MIRATI THERAPEUTICS

SN 90739574·Reg 6713167·Filed May 27, 2021

Owner Mirati Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MIRATI THERAPEUTICS (Serial No. 90739574), Registration No. 6713167, is a registered US trademark filed on May 27, 2021 by Mirati Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: April 26, 2028

Mark Intelligence

MIRATI THERAPEUTICS (Reg. #6713167) is a registered US trademark that has been protecting its owner, Mirati Therapeutics, Inc., since 2021. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 27, 2021

SERIAL

90739574

REG#

6713167

REGISTERED

Apr 26, 2022

Filing Information

StatusREGISTERED

Filing DateMay 27, 2021

Serial Number90739574

Registration No.6713167

Registration DateApr 26, 2022

Status DateApr 26, 2022

Published for OppositionFeb 08, 2022

Filing Basis & Declarations

Filed as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Apr 30, 2013

First use in commerce: Apr 30, 2013

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

19 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 25, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 25, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 25, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Apr 26, 2022

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Feb 08, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 08, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 19, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jan 05, 2022

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Jan 04, 2022

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 03, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 01, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 30, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 30, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Nov 08, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 08, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 08, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 01, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 23, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 31, 2021

NEW APPLICATION ENTERED

Other Marks by Mirati Therapeutics, Inc.

Additional USPTO filings from the same owner.

MIR

MIRATI

86363098

Mirati Therapeutics, Inc.

REGISTERED

MIR

MIRATI

90796207

Mirati Therapeutics, Inc.

REGISTERED

MMX

97481214

Mirati Therapeutics, Inc.

REGISTERED

KRA

KRAZATI

97541596

Mirati Therapeutics, Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

MIR

MIRATI

86363098

Mirati Therapeutics, Inc.

REGISTERED

MIR

MIRATI

90739531

Mirati Therapeutics, Inc.

REGISTERED

DEL

DELPHIAN THERAPEUTICS

98830481

Schedule 1 Therapeutics, Inc.

REGISTERED

CON

CONSYNANCE THERAPEUTICS

86749993

ConSynance Therapeutics, Inc.

REGISTERED

Other Marks by Marilyn F. Kelly

Additional USPTO filings handled by the same attorney of record.

BOL

BOLDER SCIENCE

88303506

REGISTERED

BOL

BOLDER SCIENCE

88312560

REGISTERED

TOM

TOMORROW'S INNOVATORS IN SCIENCE, TECHNOLOGY, ENGINEERING AND MATH

98978549

REGISTERED

EMP

EMPLICITI

99424859

REGISTERED

MIRATI THERAPEUTICS

Run a conflict check

Other Marks by Mirati Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Marilyn F. Kelly

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company